Total Payments
$2,549
2023 Payments
$79.69
Companies
22
Transactions
191
Medicare Patients
2,953
Medicare Billing
$288,426
Payment Breakdown by Category
Food & Beverage$2,520 (98.9%)
Education$28.89 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,520 | 189 | 98.9% |
| Education | $28.89 | 2 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $329.50 | 10 | $0 (2018) |
| Novo Nordisk Inc | $323.44 | 20 | $0 (2022) |
| PFIZER INC. | $303.28 | 58 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $246.90 | 15 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $233.36 | 19 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $227.64 | 15 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $140.39 | 9 | $0 (2020) |
| Amgen Inc. | $128.40 | 8 | $0 (2019) |
| ABBVIE INC. | $103.75 | 5 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $91.53 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $79.69 | 4 | GlaxoSmithKline, LLC. ($29.68) |
| 2022 | $269.88 | 15 | Takeda Pharmaceuticals U.S.A., Inc. ($173.17) |
| 2021 | $30.90 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($30.90) |
| 2020 | $157.05 | 9 | AstraZeneca Pharmaceuticals LP ($31.08) |
| 2019 | $556.49 | 44 | Novo Nordisk Inc ($176.41) |
| 2018 | $609.61 | 45 | Merck Sharp & Dohme Corporation ($106.08) |
| 2017 | $845.33 | 72 | Allergan Inc. ($281.95) |
All Payment Transactions
191 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/18/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: RESPIRATORY | ||||||
| 03/01/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: Cardio-renal | ||||||
| 01/17/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: VACCINES | ||||||
| 12/19/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $0.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: VACCINES | ||||||
| 09/09/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Diabetes | ||||||
| 07/01/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: NEUROSCIENCE | ||||||
| 02/10/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Diabetes | ||||||
| 01/27/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: NEUROSCIENCE | ||||||
| 03/10/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.55 | General |
| 02/21/2020 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: GASTROINTESTINAL | ||||||
| 02/20/2020 | PFIZER INC. | CHANTIX (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/13/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 788 | 939 | $242,368 | $81,905 |
| 2022 | 11 | 701 | 879 | $235,697 | $75,757 |
| 2021 | 13 | 689 | 869 | $236,291 | $73,167 |
| 2020 | 13 | 775 | 970 | $186,291 | $57,597 |
Total Patients
2,953
Total Services
3,657
Medicare Billing
$288,426
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 17 | 18 | $9,082 | $2,940 | 32.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 15 | 15 | $6,264 | $2,511 | 40.1% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 14 | 14 | $3,234 | $1,757 | 54.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $6,761 | $1,703 | 25.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 42 | 42 | $1,918 | $766.50 | 40.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 36 | 36 | $1,620 | $597.20 | 36.9% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 26 | 26 | $884.00 | $531.88 | 60.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 14 | 14 | $630.00 | $232.24 | 36.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 14 | 15 | $573.00 | $153.92 | 26.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 158 | 259 | $70,707 | $19,337 | 27.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 144 | 144 | $41,472 | $16,521 | 39.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 147 | 232 | $43,616 | $10,575 | 24.2% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 27 | 27 | $6,237 | $3,166 | 50.8% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 17 | 21 | $9,681 | $2,843 | 29.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 65 | 65 | $2,925 | $1,159 | 39.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $4,576 | $1,057 | 23.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 48 | 49 | $2,205 | $810.61 | 36.8% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 38 | 39 | $1,326 | $759.90 | 57.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2020 | 42 | 42 | $1,890 | $737.52 | 39.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 30 | 30 | $1,350 | $493.80 | 36.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 34 | 35 | $210.00 | $101.82 | 48.5% |
| 81003 | Automated urinalysis test | Office | 2020 | 14 | 16 | $96.00 | $35.70 | 37.2% |
About Dr. David Hughes, M.D
Dr. David Hughes, M.D is a Family Medicine healthcare provider based in Oldsmar, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831285543.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Hughes, M.D has received a total of $2,549 in payments from pharmaceutical and medical device companies, with $79.69 received in 2023. These payments were reported across 191 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,520).
As a Medicare-enrolled provider, Hughes has provided services to 2,953 Medicare beneficiaries, totaling 3,657 services with total Medicare billing of $288,426. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Oldsmar, FL
- Active Since 10/04/2006
- Last Updated 03/31/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1831285543
Products in Payments
- TRINTELLIX (Drug) $204.07
- FARXIGA (Drug) $167.54
- JANUVIA (Drug) $140.00
- NAMENDA XR (Drug) $139.42
- LINZESS (Drug) $109.79
- CHANTIX (Drug) $97.82
- INVOKANA (Drug) $91.53
- Tresiba (Drug) $79.40
- Ozempic (Drug) $78.54
- LYRICA (Drug) $73.25
- UBRELVY (Drug) $68.02
- Prolia (Biological) $66.78
- JARDIANCE (Drug) $64.50
- Victoza (Drug) $64.16
- TRULICITY (Drug) $63.18
- VIBERZI (Drug) $52.41
- Uloric (Drug) $51.70
- ZOSTAVAX (Biological) $49.30
- PREVNAR - 13 (Biological) $48.10
- TRADJENTA (Drug) $45.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Oldsmar
Howard Chipman, M.d, M.D
Family Medicine — Payments: $69,441
Family Medicine $69,441
Dr. Danny Fox, M.d, M.D
Family Medicine — Payments: $3,498
Family Medicine $3,498
Dr. Juan Falla, M.d, M.D
Family Medicine — Payments: $3,116
Family Medicine $3,116
Robert Dimasi, D.o, D.O
Family Medicine — Payments: $772.14
Family Medicine $772.14
Annie Thomas, Md, MD
Family Medicine — Payments: $495.26
Family Medicine $495.26
Naxdaris Gonzalez, Md, MD
Family Medicine
Family Medicine